3LMS

structure of human activated thrombin-activatable fibrinolysis inhibitor, tafia, in complex with tick-derived funnelin inhibitor, tci.

• Total interactions analyzed: 1
• Total true interactions: 1
• Strongest Interaction:
  • Chains: A-B
  • Int. Res.: 120
  • Norm. En. per Res.: -3.1612
• Hub Node: A(1)

All Interactions

Chains	Hydro. Bond Ener. (kJ/mol)	Elec. Ener. (kJ/mol)	VDW. Ener. (kJ/mol)	Tot. Stab. Ener. (kJ/mol)	#int. res.	# Short cont.	#Hydr. int.	#VDW pairs	#salt bridges	#Pot. fav. elec. int	#Pot. unfav. elec. int
A-B	-65.7528	6.7497	-320.34	-379.3432	120	12	3	11968	0	29	30

Interface residues

• A-B: ALA156A, ALA250A, ARG124A, ARG127A, ARG130A, ARG145A, ARG210A, ARG52B, ARG71A, ASN123A, ASN144A, ASN16A, ASN1B, ASN48B, ASP117A, ASP142A, ASP15B, ASP273A, ASP33B, ASP51B, CYS10B, CYS161A, CYS27B, CYS31B, CYS32B, CYS3B, CYS40B, CYS47B, CYS54B, CYS71B, GLN11A, GLN13B, GLN200A, GLN53B, GLU153A, GLU154A, GLU163A, GLU17A, GLU245A, GLU270A, GLU283A, GLU2B, GLU46B, GLU56B, GLU72A, GLY155A, GLY243A, GLY26B, GLY275A, GLY278A, GLY42B, GLY44B, GLY45B, GLY7B, GLY9B, HIS13A, HIS196A, HIS201A, HIS242A, HIS69A, ILE269A, ILE68A, LEU11B, LEU247A, LEU249A, LEU271A, LEU280A, LEU34B, LEU37B, LEU57B, LEU74B, LYS121A, LYS122A, LYS128A, LYS41B, LYS43B, LYS55B, MET125A, MET195A, PHE279A, PHE8B, PRO12B, PRO251A, PRO282A, PRO49B, SER119A, SER14A, SER14B, SER157A, SER158A, SER159A, SER162A, SER197A, SER199A, SER207A, SER244A, SER28B, SER35B, SER5B, THR164A, THR246A, THR268A, THR274A, THR276A, THR29B, TRP120A, TRP126A, TRP73A, TRP73B, TYR116A, TYR118A, TYR12A, TYR165A, TYR198A, TYR248A, TYR277A, VAL203A, VAL30B, VAL4B, VAL72B